Table 5.
Intraoperative antibiotics, perioperative antibiotics, and surgical site complication in primary THA.
| Type of intraoperative antibiotic, n (%) | Skin complication (abrasion or infection) |
||
|---|---|---|---|
| No | Yes | Total | |
| Cefazolin 2g | 207 (92.8) | 16 (7.2) | 223 |
| Cefazolin 3g | 13 (100.0) | 0 (0.0) | 13 |
| Cefazolin + Clindamycin | 1 (100.0) | 0 (0.0) | 1 |
| Cefazolin + Vancomycin | 6 (85.7) | 1 (14.3) | 7 |
| Total | 227 (93.0) | 17 (7.0) | 244 |
| Frequency missing = 36 | |||
| Type of perioperative antibiotic, n (%) | |||
| TMP-SMX × 10 days | 12 (92.3) | 1 (7.7) | 13 |
| TMP-SMX × 7 days | 11 (91.7) | 1 (8.3) | 12 |
| Cephalexin 1000 mg DOS + POD1 | 176 (93.6) | 12 (6.4) | 188 |
| Cephalexin 500 mg BID × 3 d | 1 (100.0) | 0 (0.0) | 1 |
| Cephalexin 500 mg TID × 7 d | 2 (100.0) | 0 (0.0) | 2 |
| Cephalexin 500 mg TID × 7 d | 1 (100.0) | 0 (0.0 | 1 |
| Cephalexin 500 mg QID × 7 d | 5 (83.3) | 1 (16.7) | 6 |
| Cephalexin 500 mg QID × 10 d | 2 (100.0) | 0 (0.0) | 2 |
| Ciprofloxacin | 1 (100.0) | 0 (0.0) | 1 |
| Clindamycin 300 mg × 7 d | 2 (100.0) | 0 (0.0) | 2 |
| Clindamycin 600 mg DOS + POD1 | 1 (100.0) | 0 (0.0) | 1 |
| Total | 214 (93.4) | 15 (6.6) | 229 |
| Frequency missing = 51 | |||
| Type of perioperative antibiotic, n (%) | Skin complication (abrasion or infection) |
Fisher’s P-value | ||
|---|---|---|---|---|
| No | Yes | Total | ||
| TMP-SMX × 7 or 10 d | 23 (92.0) | 2 (8.0) | 25 | .6718 |
| Cephalexin 1000 mg DOS and POD1 | 176 (93.6) | 12 (6.4) | 188 | |
TMP-SMX, trimethoprim-sulfamethoxazole; DOS, day of surgery; POD1, postoperative day 1; BID, twice daily or once every 12 h; TID, 3 times daily or once every 8 h; QID, 4 times daily or once every 6 hours.